Establishing of Cancer Mission Hubs: Networks and Synergies
- Project No.: 101104587
- Project acronym: ECHoS
- Principal investigator (LSMU): prof. Elona Juozaitytė
- Project coordinator: Aicib – Agencia De Investigacao Clinica E Inovacao Biomedica, Portugal
- Funding programme: Horizon Europe
- Total project value: 6 096 147,50 Euro
- Part of the project value allocated to the LSMU: 51 281,25 Euro
- Project duration: from 2023-04-01 to 2026-03-31
- Project website: www.cancermissionhubs.eu
Cancer- healthcare, research and innovation face core common challenges, such as fragmentation of initiatives and distancing from important stakeholders, requiring coordinated solutions. These challenges are recognized in Horizon Europe’s Cancer Mission Implementation Plan and in Europe’s Beating Cancer Plan. The proposal Establishing of Cancer Mission Hubs: Networks and Synergies (ECHoS) represents a unique opportunity to coordinate R&I and Healthcare actions on cancer with policy-making processes creating transnational communication & collaboration networks aligned with Cancer Mission objectives. Experiences shows that the setup and implementation of innovative health solutions are more likely to be successful when a broad range of stakeholders and decision-makers from the public and private sectors are part of the process. ECHoS will create conditions for NCMHs to be Mission Cancer advocates in MS/AC and set the pace for the development of a transnational network of NCMHs in a second phase.
By fostering the creation of National Cancer Mission Hubs (NCMHs) in member states and associated countries ECHoS will create the conditions for organized stakeholders and individual citizens to collaborate and engage in policy dialogues. The implementation of the Cancer Mission objectives will promote more resilient and people-centric healthcare and research systems.
ECHoS will produce:
(1) general models and guidelines for the creation of sustainable NCMHs;
(2) a knowledge exchange programme to support development of NCMHs competences;
(3) impact models and training sets to help efficiently engaging with distinct stakeholders;
(4) a toolkit for synergies to help NCMH engaging in collaborative work with individual European Initiatives;
(5) a business continuity model envisaging long-term sustainability of a EU network of NCMHs;(6) a calendar of events to create awareness on NCMHs and to help closing the gap in citizens’ participation in cancer policy.
Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency (HaDEA). Neither the European Union nor the granting authority can be held responsible for them.
PROJECT PARTNERS
- SCIENSANO, Belgium;
- CYPRUS CANCER RESEARCH INSTITUTE, Cyprus;
- FAKULTNI NEMOCNICE OLOMOUC, Czechia;
- FAKULTNI NEMOCNICE U SV. ANNY V BRNE, Czechia;
- USTAV HEMATOLOGIE A KREVNI TRANSFUZE PRAHA, Czechia;
- SIHTASUTUS TARTU ULIKOOLI KLIINIKUM, Estonia;
- TARTU ULIKOOL, Estonia;
- SUOMEN SYOPAYHDISTYS -CANCERFORENINGEN I FINLAND RY – CANCER SOCIETY OF FINLAND CSF, Finland;
- HUS-YHTYMA, Finland;
- DEUTSCHES ZENTRUM FUR LUFT – UND RAUMFAHRT EV, Germany;
- ETHNIKO KENTRO TEKMIRIOSIS KAI ILEKTRONIKOU PERIECHOMENOU,Greece;
- Orszagos Onkologiai Intezet, Hungary;
- HEALTH SERVICE EXECUTIVE HSE, Ireland;
- UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN, Ireland;
- MINISTRY OF HEALTH, Israel;
- UNIVERSITA CATTOLICA DEL SACRO CUORE, Italy;
- ALLEANZA CONTRO IL CANCRO, Italy;
- FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI, Italy;
- LIETUVOS MOKSLO TARYBA, Lithuania;
- VILNIAUS UNIVERSITETAS, Lithuania;
- VIESOJI ISTAIGA VILNIAUS UNIVERSITETO LIGONINE SANTAROS KLINIKOS, Lithuania;
- NACIONALINIS VEZIO INSTITUTAS, Lithuania;
- KLAIPEDOS UNIVERSITETAS, Lithuania;
- LIETUVOS SVEIKATOS MOKSLU UNIVERSITETO LIGONINE KAUNO KLINIKOS, Lithuania;
- INSTITUT NATIONAL DU CANCER, Luxembourg;
- LUXEMBOURG INSTITUTE OF HEALTH, Luxembourg;
- MINISTRY FOR EDUCATION, SPORT, YOUTH, RESEARCH AND INNOVATION, Malta;
- Ministry for Health – Government of Malta, Malta;
- STICHTING INTEGRAAL KANKERCENTRUM NEDERLAND, Netherlands;
- KREFTFORENINGEN, Norway;
- OSLO CANCER CLUSTER SA, Norway;
- NORGES FORSKNINGSRAD, Norway;
- NARODOWE CENTRUM BADAN I ROZWOJU, Poland;
- NARODOWY INSTYTUT ONKOLOGII IM. MARII SKLODOWSKIEJ-CURIE-PANSTWOWY INSTYTUT BADAWCZY, Poland;
- ASOCIATIA CENTRUL PENTRU INOVATIE IN MEDICINA, Romania;
- NARODNY ONKOLOGICKY USTAV, Slovakia;
- NADACIA VYSKUM RAKOVINY, Slovakia;
- NACIONALNI INSTITUT ZA JAVNO ZDRAVJE, Slovenia;
- FUNDACION TECNALIA RESEARCH & INNOVATION, Spain;
- KAROLINSKA INSTITUTET, Sweden;
- REGION STOCKHOLM, Sweden;
- STIFTELSEN STOCKHOLM SCHOOL OF ECONOMICS, Sweden;
- INSTITUT NATIONAL DU CANCER GIP, France;
- TURKIYE SAGLIK ENSTITULERI BASKANLIGI, Turkey;
- RIGAS AUSTRUMU KLINISKA UNIVERSITATES SLIMNICA SIA, Latvia;
- KLINICKI BOLNICKI CENTAR SESTRE MILOSRDNICE USTANOVA, Croatia;
- MINISTERIO DA SAUDE – REPUBLICA PORTUGUESA, Portugal;
- OSLO UNIVERSITETSSYKEHUS HF, Norway;
- SINTEF AS, Norway;
- SVERIGES KOMMUNER OCH REGIONER, Sweden;
- INSTITUTO DE SALUD CARLOS III, Spain;
- EUROPEAN CANCER ORGANISATION, Belgium;
- LATVIJAS ZINATNES PADOME, Latvia;
- Augstakas izglitibas un zinatnes informacijas tehnologijas koplietosanas pakalpojumu Centrs, Latvia.